All In Biotech

Free tool

FAERS Monitor: Microzide

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020504 or its brand name (Microzide, Hydrochlorothiazide). Reports on generic versions are filed under their own applications.

Reports

146,331

Serious

98,127

67% of reports

Hospitalization

50,335

Death reported

10,200

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue10,470
  • nausea10,084
  • drug ineffective9,765
  • diarrhoea8,711
  • pain7,943
  • headache7,893
  • dyspnoea7,876
  • dizziness7,629
  • arthralgia6,349
  • off label use6,034
  • asthenia5,795
  • vomiting5,776
  • fall5,775
  • malaise5,387
  • acute kidney injury5,152

Reports by year received

View as table
YearReports
20042,310
20053,022
20063,005
20072,864
20083,115
20093,900
20105,287
20115,369
20125,907
20134,812
20146,176
20158,039
20168,663
20177,780
201810,001
201910,143
20209,294
20218,945
20228,828
20238,058
20247,549
20257,754
20265,505

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,907,828 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
acute kidney injurySignal5,1525.04.815,913
fallSignal5,7752.52.55,287
astheniaSignal5,7952.22.23,960
dizzinessSignal7,6292.22.25,140
arthralgiaSignal6,3492.22.24,241
dyspnoeaSignal7,8762.02.04,073
diarrhoea8,7112.01.94,119
fatigue10,4701.91.94,929
pain7,9431.91.83,267
nausea10,0841.81.83,981
headache7,8931.81.82,966
vomiting5,7761.81.71,975
malaise5,3871.81.71,838
drug ineffective9,7651.11.042
off label use6,0341.01.01

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.